跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11,305 条关于
“PhoreMost Limited”
全部
11,305
临床试验
1,088
药物
52
机构
1,327
资讯
8,838
3个月前
PhoreMost Unveils Lead Oncology Candidate PMC-001, a Next-Generation Oral Microtubule Targeting Agent for Brain Cancers, and Appoints Chief Medical Officer
去年
PhoreMost Unveils GlueSEEKER Platform to Accelerate Rational Molecular Glue Drug Discovery
去年
Dupilumab Shows Limited Success in Peanut Allergy Desensitization Study
去年
PharmAust Advances ALS Treatment with New Funding
去年
PARASOL Workshop Suggests Broader Proteinuria Endpoints for FSGS Drug Approval
去年
Hansoh Pharma's HS-20093 Granted Breakthrough Therapy Designation for Lung Cancer
去年
Hansoh Pharma's Aumolertinib Plus Chemotherapy Shows Positive Phase III Results in EGFR-Mutated NSCLC
去年
EMA Designates Vivesto's Paccal Vet for Limited Market in Treating Canine Hemangiosarcoma
去年
Evidence Review Finds Limited Effective Treatments for Low Back Pain
8个月前
FDA Fast-Tracks Leucovorin for Autism Treatment Despite Limited Evidence
第 1 页,共 884 页
上一页
下一页